CVA Family Office’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$153K Hold
2,022
0.02% 370
2025
Q4
$125K Hold
2,022
0.01% 375
2025
Q3
$119K Hold
2,022
0.02% 385
2025
Q2
$118K Hold
2,022
0.02% 377
2025
Q1
$100K Buy
2,022
+1,000
+98% +$51.2K 0.02% 387
2024
Q4
$45.7K Sell
1,022
-22
-2% -$1.04K 0.01% 535
2024
Q3
$50.2K Buy
1,044
+24
+2% +$1.16K 0.01% 512
2024
Q2
$51.9K Hold
1,020
0.01% 487
2024
Q1
$55.4K Buy
1,020
+1
+0.1% +$52 0.01% 472
2023
Q4
$57.4K Buy
+1,019
New +$57.6K 0.01% 447
2023
Q3
Sell
-1,000
Closed -$59K 703
2023
Q2
$59K Hold
1,000
0.01% 409
2023
Q1
$73.8K Hold
1,000
0.02% 361
2022
Q4
$73K Hold
1,000
0.02% 333
2022
Q3
$83K Hold
1,000
0.02% 269
2022
Q2
$80K Buy
+1,000
New +$97.1K 0.02% 278

Other funds holding NTR

CVA Family Office's NTR Position: Q1 2026 in Review

CVA Family Office held its Nutrien (NTR) position steady in Q1 2026 at 2,022 shares worth $153K. The position accounts for 0.02% of the portfolio, ranked #370.

CVA Family Office first reported a position in NTR in Q2 2022 and has held it in 15 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • CVA Family Office held 2,022 shares of Nutrien worth $153K as of Q1 2026.
  • CVA Family Office left its Nutrien share count unchanged in Q1 2026.
  • Nutrien made up 0.02% of CVA Family Office's portfolio in Q1 2026, its #370 holding.
  • CVA Family Office first reported a position in Nutrien in Q2 2022 and has held it in 15 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.